Hi @lloydray, I agree with other posters here that one should...

Hi @lloydray, I agree with other posters here that one should view paid research with caution. That's not to say you should disregard it, just be open minded when researching the research.

That said, I put this together on the research company that did the POH report, given they appear to be specialists in the biotech space. It's basically every initiation report they have done (11 stocks in total) from July 2016-end 2017 (I ignored 2018 reports on the basis that they should be allowed time to play out). In relation to hitting their base case SP targets, they seem to have en excellent record IMO.

Obviously the SP can come back below these levels, particularly in the biotech space. But from a trading perspective, once could assume that there is a 72% chance of the base case target being hit in a short space of time.

This is all assumption of course, but this firm does have a solid record IMO.

I'm going to start preparing these as a rule, very helpful exercise.